Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 314 entries
Sorted by: Best Match Show Resources per page

Heart failure reviews

Saad JM, Ahmed AI, Han Y, Saeed S, Pournazari P, Al-Mallah MH.
PMID: 34709500
Heart Fail Rev. 2021 Oct 28; doi: 10.1007/s10741-021-10174-x. Epub 2021 Oct 28.

Cardiac amyloidosis (CA) is an underdiagnosed form of restrictive cardiomyopathy leading to a rapid progression into heart failure. Evaluation of CA requires a multimodality approach making use of echocardiography, cardiac magnetic imaging, and nuclear imaging. Technetium (Tc)-labeled cardiac scintigraphy...

Assessing the future risks of subsequent pregnancies in peripartum cardiomyopathy.

Heart failure reviews

Port Z, Ammari Z, Babapoor-Farrokhran S, Bozorgnia B.
PMID: 33433773
Heart Fail Rev. 2021 Jan 12; doi: 10.1007/s10741-021-10075-z. Epub 2021 Jan 12.

Peripartum cardiomyopathy is a myocardial disease process which occurs in young women either in late pregnancy or the early postpartum period. Due to the young age of women effected by this disease, many of these patients elect to pursue...

Cardiorespiratory fitness in patients with type 2 diabetes: A missing piece of the puzzle.

Heart failure reviews

Tadic M, Grassi G, Cuspidi C.
PMID: 32803640
Heart Fail Rev. 2021 Mar;26(2):301-308. doi: 10.1007/s10741-020-10015-3.

Functional capacity represents an important predictor for cardiovascular and all-cause mortality in patients with diabetes mellitus (DM). Impaired cardiopulmonary fitness is frequently seen in DM patients, and it might partly explain morbidity and mortality in these patients. There are...

Heart-lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement.

Heart failure reviews

Dandel M.
PMID: 33864580
Heart Fail Rev. 2021 Apr 17; doi: 10.1007/s10741-021-10108-7. Epub 2021 Apr 17.

Due to the SARS-CoV-2 infection-related severe pulmonary tissue damages associated with a relative specific widespread thrombotic microangiopathy, the pathophysiologic role of heart-lung interactions becomes crucial for the development and progression of right ventricular (RV) dysfunction. The high resistance in...

Clinical management of amyloid cardiomyopathy.

Heart failure reviews

Kim MM, Kolseth CM, Carlson D, Masri A.
PMID: 34471997
Heart Fail Rev. 2021 Sep 01; doi: 10.1007/s10741-021-10159-w. Epub 2021 Sep 01.

Clinical heart failure, restrictive cardiomyopathy, and arrhythmias are hallmark features of amyloid cardiomyopathy. In contrast to the advancements in targeted therapies, there is a general lack of evidence-based practice guidelines for clinical management of amyloid cardiomyopathy. In this review,...

Cost-effectiveness analysis of mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation: a systematic review.

Heart failure reviews

Rezapour A, Azari S, Arabloo J, Pourasghari H, Behzadifar M, Alipour V, Omidi N, Sadeghian S, Aghajani H, Bragazzi NL.
PMID: 33230582
Heart Fail Rev. 2021 May;26(3):587-601. doi: 10.1007/s10741-020-10055-9. Epub 2020 Nov 24.

To assess the cost-effectiveness of mitral valve repair with the MitraClip delivery system for patients with mitral regurgitation and heart failure, a systematic literature search was conducted in various electronic databases to January 3, 2020. Eligibility criteria are the...

Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis.

Heart failure reviews

Zhang B, Guo S, Fu Z, Liu Z.
PMID: 33811570
Heart Fail Rev. 2021 Apr 03; doi: 10.1007/s10741-021-10102-z. Epub 2021 Apr 03.

Many studies have reported various minimally invasive techniques for continuous-flow left ventricular assist device implantation. There is no consensus on whether minimally invasive techniques can bring more benefits for patients compared with the conventional technique, due to the limited...

The CORolla device for energy transfer from systole to diastole: a novel treatment for heart failure with preserved ejection fraction.

Heart failure reviews

Feld Y, Reisner Y, Meyer-Brodnitz G, Hoefler R.
PMID: 33839990
Heart Fail Rev. 2021 Apr 11; doi: 10.1007/s10741-021-10104-x. Epub 2021 Apr 11.

It is estimated that 30 to 50% of heart failure patients have heart failure with preserved ejection fraction (HFpEF). Mortality is high in this patient population, and morbidity and rate of hospitalization are similar to those of heart failure...

Sodium-glucose co-transporter 2 inhibitors and heart failure-the present and the future.

Heart failure reviews

Nana M, Morgan H, Bondugulapati LNR.
PMID: 32020487
Heart Fail Rev. 2021 Jul;26(4):953-960. doi: 10.1007/s10741-020-09925-z.

Type 2 diabetes mellitus is associated with an increased risk of heart failure. The prevalence of type 2 diabetes mellitus is on an upward trend. Heart failure represents one of the major causes for hospitalisation and mortality despite advances...

Right ventricular involvement in cancer therapy-related cardiotoxicity: the emerging role of strain echocardiography.

Heart failure reviews

Keramida K, Farmakis D.
PMID: 32128669
Heart Fail Rev. 2021 Sep;26(5):1189-1193. doi: 10.1007/s10741-020-09938-8.

The involvement of the right ventricle (RV) in various cardiovascular pathologies is usually explored and demonstrated after thorough research of the left ventricle (LV). This is also true in cardio-oncology, where multimodality imaging with cardiac magnetic resonance and nuclear...

Environmentally responsive hydrogels for repair of cardiovascular tissue.

Heart failure reviews

Guan S, Li J, Zhang K, Li J.
PMID: 32076909
Heart Fail Rev. 2021 Sep;26(5):1273-1285. doi: 10.1007/s10741-020-09934-y.

Cardiovascular diseases (CVDs) pose a serious threat to human health, which are characterized by high disability and mortality rate globally such as myocardial infarction (MI), atherosclerosis, and heart failure. Although stem cells transplantation and growth factors therapy are promising,...

Serum potassium and heart failure: association, causation, and clinical implications.

Heart failure reviews

Sfairopoulos D, Arseniou A, Korantzopoulos P.
PMID: 33098029
Heart Fail Rev. 2021 May;26(3):479-486. doi: 10.1007/s10741-020-10039-9. Epub 2020 Oct 23.

Dyskalemia (hypo- and hyperkalemia) is a common clinical encounter in patients with heart failure (HF), linked to underlying pathophysiologic alterations, pharmacological treatments, and concomitant comorbidities. Both hypo- and hyperkalemia have been associated with a poor outcome in HF. However,...

Showing 25 to 36 of 314 entries